And, yet another recall has just been announced in the news. But, this time, although you may think you are simply going to relieve your stuffy nose symptoms, due to a nasty bacteria, you may be getting more than you bargained for!
The U.S. Food and Drug Administration has just announced a voluntary nationwide recall of a nasal decongestant. The recall includes more than 34,000 bottles of Nostrilla nasal decongestant that have been pulled from the market because they may have bacterial contamination.
The Nostrilla recall was announced on October 19, by the FDA and the manufacturers, Insight Pharmaceuticals, after internal investigations discovered excessive amounts of the bacteria Burkholderia Cepacia. There have been no illnesses reported in connection with the contaminated nasal decongestant.
Gary R. Downing, CEO of Insight Pharmaceuticals, LLC, stated, “It is our commitment to our customers to provide them with products they can rely on as safe and effective for their FDA-approved uses,” And, “Through our standard testing procedures and protocols, we discovered the potential presence of a bacterial contaminant in one lot of Nostrilla, and reported it to the FDA. Consumer safety is our #1 priority, and we’ll take all necessary action to ensure Nostrilla, as well as all of our products, comply with FDA regulations and requirements.”
The recall affects one lot of Nostrilla Nasal Decongestant consisting of 34,092 1/2 ounce plastic bottles. The bottles will be labeled with lot # 11G075 and an expiration date of 05/2014 stamped on the side. The bottles were distributed nationwide in pharmacies and retail outlets.
The effects of a Burkholderia Cepacia infection may vary widely. While some individuals may exhibit no symptoms at all, others could experience serious respiratory infections. The bacteria has also been known to cause “foot-rot” among soldiers though it is more commonly associated with the development of serious health conditions in individuals with cystic fibrosis (CF) and those with chronic lung disease.
For individuals with existing health problems, Burkholderia Cepacia can attack the lungs and deterioration may be gradual or accelerated depending on the health of the person and on the type of Burkholderia Cepacia. In some cases, the bacteria could lead to pneumonia and death.
Consumers who have purchased “Nostrilla Decongestant, lot #11G075” are urged to return the product and contact the company at 1-877-546-9059 Monday through Friday from 9 am-5 pm EST time zone. Also, the FDA recommends that consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product.